|
Equilenin
|
D06.472.334.851.437.249 |
|
|
Pharmacology
|
H02.628 |
|
|
Bisbenzimidazole
|
D03.633.100.103.145 |
|
|
Ectodermal Dysplasia 3, Anhidrotic
|
C16.320.850.250.298 |
|
|
Mediation Analysis
|
E05.318.740.400.500 |
|
|
Factor Analysis, Statistical
|
E05.318.740.400 |
|
|
Tachycardia, Paroxysmal
|
C14.280.067.845.695 |
|
|
Phoradendron
|
B01.650.940.800.575.912.250.884.333 |
|
|
Benomyl
|
D03.633.100.103.140 |
|
|
Myosin Type IV
|
D12.776.220.525.475.681 |
|
|
Nephrology Nursing
|
H02.478.676.514 |
|
|
Flaviviridae
|
B04.820.578.344 |
|
|
Stapes Mobilization
|
E04.580.450.731.681 |
|
|
Stapes Surgery
|
E04.580.450.731 |
|
|
Pheophytins
|
D03.383.129.578.840.374.700 |
|
|
Primary Health Care
|
N04.590.233.727 |
|
|
Risk
|
E05.318.740.600.800 |
|
|
Fluorophotometry
|
E05.196.712.516.600.410 |
|
|
Thymocytes
|
A11.148.378.294.750.800 |
|
|
Precursor Cells, T-Lymphoid
|
A11.148.378.294.750 |
|
